Trond Atle Smedsrud, EVP Strategic Investments, has on 19 November 2020 purchased 4 800 shares in Aker BioMarine AS at an average price of NOK 88,10 per share through his wholly-owned investment company Hawi Holding AS. The shares were acquired on Merkur Market. Following the transaction, Smedsrud holds a total of 4 800 shares in Aker BioMarine AS.

Katrine Klaveness, Chief Financial Officer, purchased on 3 November 4 450 shares in Aker BioMarine AS at an average price of NOK 83 per share. The shares were acquired on Merkur Market. Following the transaction, Klaveness holds a total of 4 450 shares in Aker BioMarine AS.
 
Sigve Nordrum, EVP Animal Health and Nutrition, purchased on 30 October 4 600 shares in Aker BioMarine AS at an average price of NOK 80,90 per share. The shares were acquired on Merkur Market. Following the transaction, Nordrum holds a total of 5 600 shares in Aker BioMarine AS.
 
Shauna Mcneill, EVP Innovation, purchased on 30 October 4 870 shares in Aker BioMarine AS at an average price of NOK 81,95 per share. The shares were acquired on Merkur Market. Following the transaction, Mcneill holds a total of 4 870 shares in Aker BioMarine AS.
 
Tim de Haas, EVP Human Health and Nutrition, purchased on 30 October 4 650 shares in Aker BioMarine AS at an average price of NOK 81,95 per share. The shares were acquired on Merkur Market. Following the transaction, de Haas holds a total of 4 650 shares in Aker BioMarine AS.
 
Tone Lorentzen, EVP Supply Chain, purchased on 2 November 4 500 shares in Aker BioMarine AS at an average price of NOK 83,80 per share. The shares were acquired on Merkur Market. Following the transaction, Lorentzen holds a total of 4 500 shares in Aker BioMarine AS.